Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19.
Paweł PiwowarczykMarta SzczukockaWojciech CiosPaulina OkuńskaGrzegorz RaszewskiMichał BorysPaweł WiczlingMirosław CzuczwarPublished in: Clinical pharmacokinetics (2023)
ClinicalTrials.gov identifier no. NCT05621915.